Longevity & AgingPeter Attia Builds a Practical Framework for Getting Real Value From Genetic Tests
Peter Attia walks through the often-misunderstood world of genetic testing, explaining why more data does not always mean more clarity. He draws a key distinction between deterministic findings — like BRCA mutations or inherited cardiac conditions — and probabilistic risk scores that rarely change clinical management. Attia argues that directly measuring the phenotype (cholesterol levels, imaging, glucose) is often more informative than inferring risk from genetics alone. The episode covers cardiovascular disease, cancer risk, neurodegeneration, pharmacogenetics, and the largely evidence-free world of functional medicine genetic panels. A practical decision framework is offered: genetic testing is most valuable when there is a clear clinical question, an appropriate test type, and a result that can meaningfully change what you do next.
